Iovance Biotherapeutics Inc Strategic Asset Allocation Index
Iovance Biotherapeutics Inc strategic asset allocation index. Iovance Biotherapeutics Inc (IOVA) has a Strategic Asset Allocation Index of 19.5% as of June 2023. Strategic assets (PP&E of $112.55 Million plus long-term investments of $-) total $112.55 Million, measured against net assets of $578.57 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See IOVA equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Iovance Biotherapeutics Inc (2013–2022)
Strategic asset allocation index of Iovance Biotherapeutics Inc from 2013 to 2022. This chart shows how Iovance Biotherapeutics Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 19.5%, representing strategic assets of $112.55 Million against net assets of $578.57 Million USD. Check Iovance Biotherapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Iovance Biotherapeutics Inc Strategic Asset Allocation Index by Year (2013–2022)
Iovance Biotherapeutics Inc strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Iovance Biotherapeutics Inc from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see IOVA market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 35.7% | $178.25 Million | $178.25 Million | $0.00 | $499.64 Million | ▲ +4.7 pp |
| 2021 | 31.0% | $192.53 Million | $100.94 Million | $91.59 Million | $621.66 Million | ▲ +22.0 pp |
| 2020 | 9.0% | $59.16 Million | $59.16 Million | $0.00 | $656.50 Million | ▲ +6.2 pp |
| 2019 | 2.9% | $8.54 Million | $8.54 Million | $- | $298.97 Million | ▲ +2.3 pp |
| 2018 | 0.6% | $2.68 Million | $2.68 Million | $- | $466.19 Million | ▼ -1.1 pp |
| 2017 | 1.7% | $2.45 Million | $2.45 Million | $- | $145.48 Million | ▲ +0.3 pp |
| 2016 | 1.4% | $2.37 Million | $2.37 Million | $- | $166.92 Million | ▼ -0.2 pp |
| 2015 | 1.6% | $1.68 Million | $1.68 Million | $- | $104.02 Million | ▼ -1.8 pp |
| 2014 | 3.4% | $1.53 Million | $1.53 Million | $- | $44.85 Million | ▲ +3.3 pp |
| 2013 | 0.2% | $27.76K | $27.76K | $- | $17.60 Million | — |